28 Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Aldeyra Therapeutics Inc ALDX rose 65.3 percent to $11.80 in pre-market trading after the company's phase 3 trial for allergic conjunctivitis met its primary endpoint.
• NanoViricides Inc NNVC rose 41.5 percent to $0.44 in pre-market trading after the company requested a meeting with the FDA to prepare for a clinical trial.
• Hunter Maritime Acquisition Corp. HUNT rose 22.2 percent to $22.49 in pre-market trading after surging 96.90 percent on Monday.
• Bed Bath & Beyond Inc. BBBY shares rose 19.2 percent to $16.53 in pre-market trading following media reports that three activist hedge funds plan to launch a proxy fight to replace all 12 current board members. Raymond James upgraded Bed Bath & Beyond from Market Perform to Strong Buy.
• Biocept Inc BIOC rose 13.6 percent to $1.17 in pre-market trading after the company announced it would apply its EmpowerTC product to urology. Also, Maxim Group initiated coverage on the stock with a Buy rating and $3 price target.
• Inovio Pharmaceuticals Inc INO rose 9.1 percent to $3.95 in pre-market trading after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating.
• Brainstorm Cell Therapeutics Inc. BCLI rose 7.3 percent to $4.57 in pre-market trading after reporting grant of an additional new European patent for NurOwn.
• The9 Limited NCTY rose 7 percent to $2.15 in pre-market trading after falling 20.24 percent on Monday.
• BeiGene, Ltd. BGNE shares rose 5.8 percent to $133.32 in pre-market trading.
• Coupa Software Incorporated COUP rose 4.9 percent to $94.12 in pre-market trading.
• ZTO Express (Cayman) Inc. ZTO rose 4.5 percent to $18.64 in pre-market trading.
• New Age Beverages Corporation NBEV shares rose 4 percent to $5.46 in pre-market trading.
• PagSeguro Digital Ltd. PAGS rose 3.8 percent to $30.00 in pre-market trading.
• Ciena Corporation CIEN rose 3.5 percent to $38.60 in pre-market trading.
• Eyegate Pharmaceuticals Inc EYEG rose 3.1 percent to $0.40 in pre-market trading after the FDA said Eyegate is ready to move forward with a pivotal study for its Ocular Bandage Gel.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• OpGen Inc OPGN fell 35.2 percent to $0.57 in pre-market trading after the company filed a 'Notice of Effectiveness' with the SEC. This indicates the company will proceed with a stock offering.
• CAN-FITE BIOPHA/S ADR CANF fell 31 percent to $0.89 in pre-market trading after the company's phase 2 trial for advanced liver cancer did not meet its primary endpoint.
• Zomedica Pharmaceuticals Corp ZOM fell 28 percent to $0.41 in pre-market trading after the company priced a 6.52 million share stock offering at $0.46 per share.
• Catalyst Pharmaceuticals, Inc. CPRX shares fell 5.5 percent to $4.95 in pre-market trading after the company gave a corporate overview at Oppenheimer's healthcare event. Catalyst highlighted 2 possible catalysts in presentation: Phase 3 data for CMS, MuSK-MG candidates.
• Akari Therapeutics, Plc AKTX shares fell 5.2 percent to $3.50 in pre-market trading after dropping 10.00 percent on Monday.
• Aptose Biosciences Inc. APTO fell 4.9 percent to $2.16 in pre-market trading.
• Inphi Corporation IPHI fell 4.5 percent to $41.12 in pre-market trading.
• China Bat Group, Inc. GLG fell 4.4 percent to $2.39 in pre-market trading after rising 6.84 percent on Monday.
• Orion Group Holdings, Inc. ORN fell 3.8 percent to $3.07 in pre-market trading after reporting Q4 results.
• Myokardia Inc MYOK fell 3.6 percent to $50.01 in pre-market trading after reporting a $200 million offering of common stock.
• iQIYI, Inc. IQ fell 3.6 percent to $23.15 in pre-market trading after the company announced a $1.05 billion convertible note offering.
• Cheetah Mobile Inc. CMCM fell 3.4 percent to $6.77 in pre-market trading after rising 3.55 percent on Monday.
• Cronos Group Inc CRON fell 2 percent to $20.12 in pre-market trading following FY18 results.